This report provides a comprehensive analysis of the global dural biological patch market, projecting steady growth through 2032. It examines the industry through various segmentations, including material type, fixation method, and surgical application across cranial and spinal procedures. Key market drivers include the rising prevalence of neurological disorders and advancements in regenerative medicine, alongside challenges regarding disease transmission risks. The study evaluates competitive landscapes, regional developments, and strategic trends to identify emerging opportunities within the neurosurgical sector.

Market Overview

The global Dural Biological Patch market size is predicted to grow from US$ 701 million in 2025 to US$ 1036 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

Product Definition and Utility

A dural biological patch is made from natural biological materials such as collagen, animal-derived tissues, and extracellular matrices. These patches are used in neurosurgery to repair or reconstruct the dura mater. They promote tissue regeneration and are often preferred for their biological compatibility and ability to integrate with the surrounding tissue.

Market Statistics (2025)

• Global Sales Volume: Approximately 1,834 K Pcs
• Average Global Market Price: Around US$ 391/Pcs
• Gross Profit Margins: Vary significantly among manufacturers, ranging from approximately 80% to 95%.

Market Dynamics

Growth Drivers

• Biocompatibility and Healing: Biological dural patches are preferred in situations where tissue regeneration and optimal healing are required. The ability of these patches to integrate seamlessly with human tissue is a significant driver for their use in complex brain and spinal surgeries.
• Increasing Prevalence of Neurological Disorders: The rising incidence of neurological conditions, including traumatic brain injuries, brain tumors, and spinal cord injuries, is pushing the demand for dural repair materials like biological patches.
• Personalized Medicine and Regenerative Medicine: Advances in regenerative medicine are enhancing the development of biological dural patches, particularly with regard to tissue regeneration and the reduction of rejection rates.
• Expanding Neurosurgery Markets in Developing Countries: As the healthcare infrastructure in emerging markets continues to develop, there is a growing demand for advanced, biocompatible surgical products like biological dural patches.

Market Challenges and Research Focus

• Risk of Disease Transmission: Although extensively screened, biological materials sourced from animals can carry a risk of disease transmission, which may deter some healthcare providers from using these products in certain surgeries.
• Focus on Safety and Efficacy: The ongoing research in tissue engineering and biological materials aims to further enhance the safety, efficacy, and long-term outcomes of biological dural patches.

Report Scope and Methodology

LP Information, Inc. (LPI) ' newest research report, the “Dural Biological Patch Industry Forecast” looks at past sales and reviews total world Dural Biological Patch sales in 2025, providing a comprehensive analysis by region and market sector of projected Dural Biological Patch sales for 2026 through 2032. With Dural Biological Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dural Biological Patch industry.

This Insight Report provides a comprehensive analysis of the global Dural Biological Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dural Biological Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dural Biological Patch market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dural Biological Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dural Biological Patch. This report presents a comprehensive overview, market shares, and growth opportunities of Dural Biological Patch market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

By Type

• Bovine Derived Materials
• Porcine Derived Materials
• Other

By Fixation Method

• Suturable
• Onlay

By Surgical Application Scenario

• Cranial
• Spinal

By Application

• Public Hospital
• Private Hospital

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on inputs gathered from primary experts and analysis of company coverage, product portfolio, and market penetration:

• Integra LifeSciences
• Tianxinfu Medical Appliance
• B. Braun (Aesculap)
• Johnson & Johnson
• Baxter
• Guanhao Biotech
• Zhenghai Bio-Tech
• Evergen
• Regenity
• Balance Medical
• Bonsci Technology
• Biosis Healing Biological
• Cingular Biotechnology

Key Questions Addressed

• What is the 10-year outlook for the global Dural Biological Patch market?
• What factors are driving Dural Biological Patch market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Dural Biological Patch market opportunities vary by end market size?
• How does Dural Biological Patch break out by Type, by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Dural Biological Patch Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Dural Biological Patch by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Dural Biological Patch by Country/Region, 2021, 2025 & 2032

  • 2.2 Dural Biological Patch Segment by Type

    • 2.2.1 Bovine Derived Materials

    • 2.2.2 Porcine Derived Materials

    • 2.2.3 Other

    • 2.2.4 Dural Biological Patch Sales by Type

      • 2.2.4.1 Global Dural Biological Patch Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Dural Biological Patch Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Dural Biological Patch Sale Price by Type (2021-2026)

  • 2.3 Dural Biological Patch Segment by Fixation Method

    • 2.3.1 Suturable

    • 2.3.2 Onlay

    • 2.3.3 Dural Biological Patch Sales by Fixation Method

      • 2.3.3.1 Global Dural Biological Patch Sales Market Share by Fixation Method (2021-2026)
      • 2.3.3.2 Global Dural Biological Patch Revenue and Market Share by Fixation Method (2021-2026)
      • 2.3.3.3 Global Dural Biological Patch Sale Price by Fixation Method (2021-2026)

  • 2.4 Dural Biological Patch Segment by Surgical Application Scenario

    • 2.4.1 Cranial

    • 2.4.2 Spinal

    • 2.4.3 Dural Biological Patch Sales by Surgical Application Scenario

      • 2.4.3.1 Global Dural Biological Patch Sales Market Share by Surgical Application Scenario (2021-2026)
      • 2.4.3.2 Global Dural Biological Patch Revenue and Market Share by Surgical Application Scenario (2021-2026)
      • 2.4.3.3 Global Dural Biological Patch Sale Price by Surgical Application Scenario (2021-2026)

  • 2.5 Dural Biological Patch Segment by Application

    • 2.5.1 Public Hospital

    • 2.5.2 Private Hospital

    • 2.5.3 Dural Biological Patch Sales by Application

      • 2.5.3.1 Global Dural Biological Patch Sale Market Share by Application (2021-2026)
      • 2.5.3.2 Global Dural Biological Patch Revenue and Market Share by Application (2021-2026)
      • 2.5.3.3 Global Dural Biological Patch Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Dural Biological Patch Breakdown Data by Company

    • 3.1.1 Global Dural Biological Patch Annual Sales by Company (2021-2026)

    • 3.1.2 Global Dural Biological Patch Sales Market Share by Company (2021-2026)

  • 3.2 Global Dural Biological Patch Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Dural Biological Patch Revenue by Company (2021-2026)

    • 3.2.2 Global Dural Biological Patch Revenue Market Share by Company (2021-2026)

  • 3.3 Global Dural Biological Patch Sale Price by Company

  • 3.4 Key Manufacturers Dural Biological Patch Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Dural Biological Patch Product Location Distribution

    • 3.4.2 Players Dural Biological Patch Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Dural Biological Patch by Geographic Region

  • 4.1 World Historic Dural Biological Patch Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Dural Biological Patch Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Dural Biological Patch Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Dural Biological Patch Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Dural Biological Patch Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Dural Biological Patch Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Dural Biological Patch Sales Growth

  • 4.4 APAC Dural Biological Patch Sales Growth

  • 4.5 Europe Dural Biological Patch Sales Growth

  • 4.6 Middle East & Africa Dural Biological Patch Sales Growth

• 5 Americas

  • 5.1 Americas Dural Biological Patch Sales by Country

    • 5.1.1 Americas Dural Biological Patch Sales by Country (2021-2026)

    • 5.1.2 Americas Dural Biological Patch Revenue by Country (2021-2026)

  • 5.2 Americas Dural Biological Patch Sales by Type (2021-2026)

  • 5.3 Americas Dural Biological Patch Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Dural Biological Patch Sales by Region

    • 6.1.1 APAC Dural Biological Patch Sales by Region (2021-2026)

    • 6.1.2 APAC Dural Biological Patch Revenue by Region (2021-2026)

  • 6.2 APAC Dural Biological Patch Sales by Type (2021-2026)

  • 6.3 APAC Dural Biological Patch Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Dural Biological Patch by Country

    • 7.1.1 Europe Dural Biological Patch Sales by Country (2021-2026)

    • 7.1.2 Europe Dural Biological Patch Revenue by Country (2021-2026)

  • 7.2 Europe Dural Biological Patch Sales by Type (2021-2026)

  • 7.3 Europe Dural Biological Patch Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Dural Biological Patch by Country

    • 8.1.1 Middle East & Africa Dural Biological Patch Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Dural Biological Patch Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Dural Biological Patch Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Dural Biological Patch Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Dural Biological Patch

  • 10.3 Manufacturing Process Analysis of Dural Biological Patch

  • 10.4 Industry Chain Structure of Dural Biological Patch

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Dural Biological Patch Distributors

  • 11.3 Dural Biological Patch Customer

• 12 World Forecast Review for Dural Biological Patch by Geographic Region

  • 12.1 Global Dural Biological Patch Market Size Forecast by Region

    • 12.1.1 Global Dural Biological Patch Forecast by Region (2027-2032)

    • 12.1.2 Global Dural Biological Patch Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Dural Biological Patch Forecast by Type (2027-2032)

  • 12.7 Global Dural Biological Patch Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Integra LifeSciences

    • 13.1.1 Integra LifeSciences Company Information

    • 13.1.2 Integra LifeSciences Dural Biological Patch Product Portfolios and Specifications

    • 13.1.3 Integra LifeSciences Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Integra LifeSciences Main Business Overview

    • 13.1.5 Integra LifeSciences Latest Developments

  • 13.2 Tianxinfu Medical Appliance

    • 13.2.1 Tianxinfu Medical Appliance Company Information

    • 13.2.2 Tianxinfu Medical Appliance Dural Biological Patch Product Portfolios and Specifications

    • 13.2.3 Tianxinfu Medical Appliance Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Tianxinfu Medical Appliance Main Business Overview

    • 13.2.5 Tianxinfu Medical Appliance Latest Developments

  • 13.3 B. Braun (Aesculap)

    • 13.3.1 B. Braun (Aesculap) Company Information

    • 13.3.2 B. Braun (Aesculap) Dural Biological Patch Product Portfolios and Specifications

    • 13.3.3 B. Braun (Aesculap) Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 B. Braun (Aesculap) Main Business Overview

    • 13.3.5 B. Braun (Aesculap) Latest Developments

  • 13.4 Johnson & Johnson

    • 13.4.1 Johnson & Johnson Company Information

    • 13.4.2 Johnson & Johnson Dural Biological Patch Product Portfolios and Specifications

    • 13.4.3 Johnson & Johnson Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Johnson & Johnson Main Business Overview

    • 13.4.5 Johnson & Johnson Latest Developments

  • 13.5 Baxter

    • 13.5.1 Baxter Company Information

    • 13.5.2 Baxter Dural Biological Patch Product Portfolios and Specifications

    • 13.5.3 Baxter Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Baxter Main Business Overview

    • 13.5.5 Baxter Latest Developments

  • 13.6 Guanhao Biotech

    • 13.6.1 Guanhao Biotech Company Information

    • 13.6.2 Guanhao Biotech Dural Biological Patch Product Portfolios and Specifications

    • 13.6.3 Guanhao Biotech Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Guanhao Biotech Main Business Overview

    • 13.6.5 Guanhao Biotech Latest Developments

  • 13.7 Zhenghai Bio-Tech

    • 13.7.1 Zhenghai Bio-Tech Company Information

    • 13.7.2 Zhenghai Bio-Tech Dural Biological Patch Product Portfolios and Specifications

    • 13.7.3 Zhenghai Bio-Tech Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Zhenghai Bio-Tech Main Business Overview

    • 13.7.5 Zhenghai Bio-Tech Latest Developments

  • 13.8 Evergen

    • 13.8.1 Evergen Company Information

    • 13.8.2 Evergen Dural Biological Patch Product Portfolios and Specifications

    • 13.8.3 Evergen Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Evergen Main Business Overview

    • 13.8.5 Evergen Latest Developments

  • 13.9 Regenity

    • 13.9.1 Regenity Company Information

    • 13.9.2 Regenity Dural Biological Patch Product Portfolios and Specifications

    • 13.9.3 Regenity Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Regenity Main Business Overview

    • 13.9.5 Regenity Latest Developments

  • 13.10 Balance Medical

    • 13.10.1 Balance Medical Company Information

    • 13.10.2 Balance Medical Dural Biological Patch Product Portfolios and Specifications

    • 13.10.3 Balance Medical Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Balance Medical Main Business Overview

    • 13.10.5 Balance Medical Latest Developments

  • 13.11 Bonsci Technology

    • 13.11.1 Bonsci Technology Company Information

    • 13.11.2 Bonsci Technology Dural Biological Patch Product Portfolios and Specifications

    • 13.11.3 Bonsci Technology Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Bonsci Technology Main Business Overview

    • 13.11.5 Bonsci Technology Latest Developments

  • 13.12 Biosis Healing Biological

    • 13.12.1 Biosis Healing Biological Company Information

    • 13.12.2 Biosis Healing Biological Dural Biological Patch Product Portfolios and Specifications

    • 13.12.3 Biosis Healing Biological Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Biosis Healing Biological Main Business Overview

    • 13.12.5 Biosis Healing Biological Latest Developments

  • 13.13 Cingular Biotechnology

    • 13.13.1 Cingular Biotechnology Company Information

    • 13.13.2 Cingular Biotechnology Dural Biological Patch Product Portfolios and Specifications

    • 13.13.3 Cingular Biotechnology Dural Biological Patch Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Cingular Biotechnology Main Business Overview

    • 13.13.5 Cingular Biotechnology Latest Developments

• 14 Research Findings and Conclusion